vs
Amerant Bancorp Inc.（AMTB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Amerant Bancorp Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍（$112.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 3.0%，领先381.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 2.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 10.1%）
阿梅兰特银行是一家注册于美国佛罗里达州的本土银行，总部坐落于佛罗里达州科勒尔盖布尔斯。目前该行在佛罗里达州共设有19家实体分行，通过自有运营及合作网络可提供超过5.5万台ATM的取款服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AMTB vs RIGL — 直观对比
营收规模更大
AMTB
是对方的1.6倍
$69.8M
营收增速更快
RIGL
高出18.3%
2.9%
净利率更高
RIGL
高出381.0%
3.0%
两年增速更快
RIGL
近两年复合增速
10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.2M | $69.8M |
| 净利润 | $2.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 1.7% | 33.2% |
| 净利率 | 3.0% | 384.0% |
| 营收同比 | 2.9% | 21.2% |
| 净利润同比 | -84.0% | 1769.2% |
| 每股收益（稀释后） | $0.08 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTBRIGL
| Q4 25 | $112.2M | $69.8M | ||
| Q3 25 | $111.4M | $69.5M | ||
| Q2 25 | $110.3M | $101.7M | ||
| Q1 25 | $105.4M | $53.3M | ||
| Q4 24 | $87.6M | $57.6M | ||
| Q3 24 | $33.3M | $55.3M | ||
| Q2 24 | $98.8M | $36.8M | ||
| Q1 24 | $92.5M | $29.5M |
净利润AMTBRIGL
| Q4 25 | $2.7M | $268.1M | ||
| Q3 25 | $14.8M | $27.9M | ||
| Q2 25 | $23.0M | $59.6M | ||
| Q1 25 | $12.0M | $11.4M | ||
| Q4 24 | $16.9M | $14.3M | ||
| Q3 24 | $-48.2M | $12.4M | ||
| Q2 24 | $5.0M | $-1.0M | ||
| Q1 24 | $10.6M | $-8.2M |
毛利率AMTBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率AMTBRIGL
| Q4 25 | 1.7% | 33.2% | ||
| Q3 25 | 17.1% | 40.9% | ||
| Q2 25 | 27.0% | 60.1% | ||
| Q1 25 | 14.6% | 23.9% | ||
| Q4 24 | 20.6% | 28.9% | ||
| Q3 24 | -185.8% | 25.4% | ||
| Q2 24 | 6.4% | 1.2% | ||
| Q1 24 | 14.6% | -23.6% |
净利率AMTBRIGL
| Q4 25 | 3.0% | 384.0% | ||
| Q3 25 | 13.2% | 40.2% | ||
| Q2 25 | 20.9% | 58.6% | ||
| Q1 25 | 11.3% | 21.5% | ||
| Q4 24 | 19.3% | 24.9% | ||
| Q3 24 | -144.6% | 22.5% | ||
| Q2 24 | 5.0% | -2.8% | ||
| Q1 24 | 11.4% | -27.9% |
每股收益（稀释后）AMTBRIGL
| Q4 25 | $0.08 | $14.11 | ||
| Q3 25 | $0.35 | $1.46 | ||
| Q2 25 | $0.55 | $3.28 | ||
| Q1 25 | $0.28 | $0.63 | ||
| Q4 24 | $0.53 | $0.82 | ||
| Q3 24 | $-1.43 | $0.70 | ||
| Q2 24 | $0.15 | $-0.06 | ||
| Q1 24 | $0.31 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $938.8M | $391.5M |
| 总资产 | $9.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AMTBRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务AMTBRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AMTBRIGL
| Q4 25 | $938.8M | $391.5M | ||
| Q3 25 | $944.9M | $117.6M | ||
| Q2 25 | $924.3M | $81.9M | ||
| Q1 25 | $906.3M | $18.6M | ||
| Q4 24 | $890.5M | $3.3M | ||
| Q3 24 | $902.9M | $-14.6M | ||
| Q2 24 | $734.3M | $-29.9M | ||
| Q1 24 | $738.1M | $-31.7M |
总资产AMTBRIGL
| Q4 25 | $9.8B | $513.6M | ||
| Q3 25 | $10.4B | $242.5M | ||
| Q2 25 | $10.3B | $206.7M | ||
| Q1 25 | $10.2B | $176.0M | ||
| Q4 24 | $9.9B | $164.0M | ||
| Q3 24 | $10.4B | $139.4M | ||
| Q2 24 | $9.7B | $128.4M | ||
| Q1 24 | $9.8B | $126.5M |
负债/权益比AMTBRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $137.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $129.2M | — |
| 自由现金流率自由现金流/营收 | 115.2% | — |
| 资本支出强度资本支出/营收 | 6.9% | — |
| 现金转化率经营现金流/净利润 | 50.71× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $225.2M | — |
8季度趋势，按日历期对齐
经营现金流AMTBRIGL
| Q4 25 | $137.0M | $22.0M | ||
| Q3 25 | $22.7M | $24.0M | ||
| Q2 25 | $57.6M | $30.5M | ||
| Q1 25 | $20.2M | $-893.0K | ||
| Q4 24 | $82.2M | $14.5M | ||
| Q3 24 | $4.2M | $21.7M | ||
| Q2 24 | $-2.3M | $302.0K | ||
| Q1 24 | $2.8M | $-5.0M |
自由现金流AMTBRIGL
| Q4 25 | $129.2M | — | ||
| Q3 25 | $21.7M | — | ||
| Q2 25 | $56.3M | — | ||
| Q1 25 | $18.0M | — | ||
| Q4 24 | $74.8M | — | ||
| Q3 24 | $2.6M | — | ||
| Q2 24 | $-3.9M | — | ||
| Q1 24 | $-694.0K | — |
自由现金流率AMTBRIGL
| Q4 25 | 115.2% | — | ||
| Q3 25 | 19.5% | — | ||
| Q2 25 | 51.0% | — | ||
| Q1 25 | 17.1% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | -3.9% | — | ||
| Q1 24 | -0.8% | — |
资本支出强度AMTBRIGL
| Q4 25 | 6.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 3.8% | — |
现金转化率AMTBRIGL
| Q4 25 | 50.71× | 0.08× | ||
| Q3 25 | 1.54× | 0.86× | ||
| Q2 25 | 2.50× | 0.51× | ||
| Q1 25 | 1.69× | -0.08× | ||
| Q4 24 | 4.87× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | -0.47× | — | ||
| Q1 24 | 0.26× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMTB
| Other | $58.0M | 52% |
| Commercial Portfolio Segment | $25.7M | 23% |
| Commercial Real Estate Portfolio Segment | $17.3M | 15% |
| Consumer Portfolio Segment | $11.1M | 10% |
RIGL
暂无分部数据
